Salminen T M, Saarenmaa I E, Heikkilä M M, Hakama M
Tampere School of Public Health, University of Tampere, Finland.
Breast Cancer Res Treat. 1999 Sep;57(2):165-73. doi: 10.1023/a:1006235206513.
The purpose of the study was to estimate the incidence of unfavourable mammographic pattern by risk factors of breast cancers. Data consisted of 1890 Finnish women with mammographic pattern of either N1 or P1 (Wolfe's classification) at the initial screening. The screening was repeated every second year from 1982 to 1990 and at each screening round the mammographic pattern was assessed. The incidence rate of P2,DY pattern was 1.9/100 woman years. The incidence of P2,DY pattern was significantly related to age. The age-adjusted odds ratio (OR) (based on logistic regression) was 2.0 (95% CI 1.0-3.9) among women with hormonal replacement therapy (HRT), 0.6 (95% CI 0.4-0.9) among postmenopausal women, 0.2 (95% CI 0.1-0.4) among women with large breasts and 0.2 (95% CI 0.1-0.3) among women with large body mass index (BMI). After multivariate adjustment by logistic regression only the effect of BMI remained statistically significant, odds ratio of P2,DY pattern for women with BMI 25 or more was 0.2 (95% CI 0.1-0.6) compared to women with BMI less than 20.
本研究的目的是通过乳腺癌的危险因素来估计不良乳腺钼靶影像模式的发生率。数据来自1890名芬兰女性,她们在初次筛查时乳腺钼靶影像模式为N1或P1(沃尔夫分类法)。从1982年至1990年,每两年进行一次筛查,每次筛查时评估乳腺钼靶影像模式。P2、DY模式的发生率为1.9/100人年。P2、DY模式的发生率与年龄显著相关。在接受激素替代疗法(HRT)的女性中,年龄调整后的优势比(OR)(基于逻辑回归)为2.0(95%可信区间1.0 - 3.9),绝经后女性中为0.6(95%可信区间0.4 - 0.9),乳房较大的女性中为0.2(95%可信区间0.1 - 0.4),体重指数(BMI)较高的女性中为0.2(95%可信区间0.1 - 0.3)。在通过逻辑回归进行多变量调整后,仅BMI的影响仍具有统计学意义,与BMI小于20的女性相比,BMI为25或更高的女性出现P2、DY模式的优势比为0.2(95%可信区间0.1 - 0.6)。